NEUROVIR THERAPEUTICS
NeuroVir Therapeutics, Inc. is , a biopharmaceutical company that develops herpes simplex virus (HSV) vectors for use as cancer therapeutics.
NEUROVIR THERAPEUTICS
Industry:
Biotechnology Health Care
Address:
San Diego, California, United States
Country:
United States
Status:
Active
Similar Organizations
Mperia Therapeutics
Mperia Therapeutics is a biotechnology company.
Neuroene Therapeutics
Neuroene Therapeutics is a startup biotechnology company.
Rekindle Therapeutics
Rekindle Therapeutics is a biotechnology company.
More informations about "Neurovir Therapeutics"
Neurovir Therapeutics - Crunchbase Company Profile & Funding
NeuroVir Therapeutics, Inc. is , a biopharmaceutical company that develops herpes simplex virus (HSV) vectors for use as cancer therapeutics.See details»
Neurovir Therapeutics Company Profile 2024: Valuation, Investors ...
Operator of a biopharmaceutical company intended to focus on cancer treatment. The company focused on developing modified herpes simplex viruses (HSV) for use in cancer therapy, …See details»
Meet the Team at Prilenia
Michael is the co-founder of 5 biotechnology companies, including Prilenia, NeuroVir Therapeutics, Inc., Xenon Pharmaceuticals Inc., Aspreva Pharmaceuticals Corp, and 89bio, …See details»
Neurovir Therapeutics Inc - Company Profile and News
NeuroVir Therapeutics, Inc. is a biotechnology company. The Company's herpes simplex virus technologies are researched for the potential treatment of tumors and for gene delivery. …See details»
CLOSING HELD FOR ACQUISITION OF NEUROVIR THERAPEUTICS, …
Jan 16, 2001 · The German biopharmaceutical company MediGene AG (NMarkt: MDG) announced today the closing of the acquisition of NeuroVir Therapeutics, Inc. (San Diego, …See details»
MediGene - Funding, Financials, Valuation & Investors - Crunchbase
Feb 1, 2021 · MediGene has acquired Neurovir Therapeutics on Nov 9, 2000. MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.See details»
MediGene takes over US firm NeuroVir - The Pharma Letter
Nov 10, 2000 · German biopharmaceutical company MediGene AG has signed an acquisitionagreement with the San Diego, USA-based NeuroVir Therapeutics, which develops …See details»
Neurovir Inc Company Profile | Vancouver, BC, Canada
Find company research, competitor information, contact details & financial data for Neurovir Inc of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
Neurovir Therapeutics - Crunchbase
NeuroVir Therapeutics, Inc. is a biotechnology company. Similar Companies. Edit Similar Companies SectionSee details»
NeuroVir Therapeutics Inc. - BioCentury Company Profiles - BCIQ
NeuroVir Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Synthetic Biologics Announces Management Transitions in …
ROCKVILLE, Md., March 23, 2022 (GLOBE NEWSWIRE) — Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to …See details»
Dr. Michael R. Hayden | Centre for Molecular Medicine and …
Oct 28, 2022 · Hayden is the co-founder of five biotechnology companies including: Prilenia, NeuroVir Therapeutics Inc., Xenon Pharmaceuticals Inc., Aspreva Pharmaceuticals Corp, and …See details»
NeuroVir Set To Take Modified Herpes Virus Into Clinical Trials
Aug 19, 1999 · By the end of the year, NeuroVir Therapeutics Inc. expects to have two products that use modified herpes simplex viruses (HSV) in Phase II and I/II trials for glioblastoma and …See details»
Brian Horsburgh, PhD – Activate Therapeutics
Brian Horsburgh is a molecular virologist with 25 years of biopharmaceutical industry experience, specifically in business development, venture capital, company building, IP management, and …See details»
Oncolytic Herpes Virus Shrinks Pediatric Gliomas
Jun 1, 2021 · In a small trial of children with progressive high-grade gliomas, direct infusions of a genetically engineered strain of herpes simplex virus (HSV) known as G207 (Treovir) elicited …See details»
NeuroVir Therapeutics | Evaluate
The latest news, comment and analysis about NeuroVir Therapeutics from the Vantage editorial team.See details»
Technology evaluation: NV-1020, MediGene - PubMed
NV-1020 is a recombinant oncolytic HSV-based virus, in development by MediGene (formerly NeuroVir) for the potential treatment of cancer. The therapy is currently undergoing phase II …See details»
Oncolytic Virotherapy Blockade by Microglia and Macrophages …
Jan 31, 2018 · Oncolytic viruses (OV) have been used as a therapeutic arsenal for specifically destroying cancer cells through oncolysis, a killing mechanism characterized by cancer cell …See details»
Developing therapeutic approaches for twenty-first-century
Mar 15, 2021 · As viral disease emergence is expected to accelerate, these data dictate a need for proactive approaches to develop broadly active family-specific and cross-family …See details»
Therapy with oncolytic viruses: progress and challenges
Jan 11, 2023 · Oncolytic viruses (OVs) are an emerging class of cancer therapeutics that offer the benefits of selective replication in tumour cells, delivery of multiple eukaryotic transgene...See details»